BiotechTube

Cariprazine

Phase 3Completed
0 watching 0 views this week📈 Rising
74
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Bipolar I Disorder

Conditions

Bipolar I Disorder

Trial Timeline

Feb 28, 2010 → Feb 29, 2012

NCT ID
NCT01059539

About Cariprazine

Cariprazine is a phase 3 stage product being developed by Richter Gedeon for Bipolar I Disorder. The current trial status is completed. This product is registered under clinical trial identifier NCT01059539. Target conditions include Bipolar I Disorder.

Hype Score Breakdown

Clinical
27
Activity
18
Company
7
Novelty
9
Community
10

Clinical Trials (3)

NCT IDPhaseStatus
NCT01104792Phase 3Completed
NCT01059539Phase 3Completed
NCT00839852Phase 2Completed

Competing Products

20 competing products in Bipolar I Disorder

See all competitors
ProductCompanyStageHype Score
OlanzapineEli LillyPhase 3
77
Valproate + Lithium + Risperidone + OlanzapineEli LillyPhase 3
77
Olanzapine + PlaceboEli LillyApproved
85
FK949EAstellas PharmaPhase 3
77
FK949EAstellas PharmaPhase 3
77
FK949E + PlaceboAstellas PharmaPhase 2/3
65
Escitalopram + Bupropion XLLupin LimitedPhase 3
77
OlanzapineEli LillyApproved
85
Olanzapine Hydrochloride + Lithium CarbonateEli LillyPhase 3
77
olanzapine + lithium + valproate + carbamazepineEli LillyPhase 3
77
OlanzapineEli LillyApproved
85
OlanzapineEli LillyPhase 3
77
LY2979165 + PlaceboEli LillyPhase 1
33
olanzapine + divalproex sodium + placeboEli LillyApproved
85
olanzapine + risperidoneEli LillyApproved
85
LY2979165 + placeboEli LillyPhase 1
33
Topiramate + PlaceboEli LillyApproved
85
olanzapineEli LillyPhase 3
77
Olanzapine + PlaceboEli LillyPhase 3
77
Brenipatide + PlaceboEli LillyPhase 2
52

Other Products from Richter Gedeon

spironolactoneApproved
82
Myo-inositol + Clomiphene CitrateApproved
82
Placebo + CariprazinePhase 3
74
RGB-14-P + Prolia®Phase 3
74
Cariprazine + PlaceboPhase 3
74